Renal transplantation is the ideal mode of renal replacement therapy.
One-, 5- and 10-year graft survival rates are currently >85%, 60-70% a
nd 40-50%, respectively. Graft loss in the first year is predominantly
due to vascular complications, acute rejection, and death with a func
tioning graft. Other significant causes of early graft dysfunction are
urological complications, delayed graft function and drug-induced nep
hrotoxicity. Subsequently, graft loss is due to chronic rejection or d
eath with a functioning graft secondary to cardiovascular disease, mal
ignancy and infection. Renal artery stenosis, chronic cyclosporin neph
rotoxicity and recurrent disease also contribute to late graft dysfunc
tion. The immunosuppressed renal transplant recipient is at long term
risk of infection and neoplasia.